PFIZER IGNITE Trademark

Trademark Overview

On Tuesday, January 24, 2023, a trademark application was filed for PFIZER IGNITE with the United States Patent and Trademark Office. The USPTO has given the PFIZER IGNITE trademark a serial number of 97766072. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, October 10, 2024. This trademark is owned by Pfizer Inc.. The PFIZER IGNITE trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Contract manufacturing in the field of pharmaceuticals

Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trial services for others; providing online non-downloadable computer software platforms for drug development
pfizer ignite

General Information

Serial Number97766072
Word MarkPFIZER IGNITE
Filing DateTuesday, January 24, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, October 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2023

Trademark Statements

Goods and ServicesContract manufacturing in the field of pharmaceuticals
Goods and ServicesPharmaceutical research and development; medical and scientific research, namely, conducting clinical trial services for others; providing online non-downloadable computer software platforms for drug development

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, February 13, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 13, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Trademark Events

Event DateEvent Description
Thursday, April 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 27, 2023NEW APPLICATION ENTERED
Monday, February 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 27, 2023ASSIGNED TO EXAMINER
Wednesday, August 2, 2023NON-FINAL ACTION WRITTEN
Wednesday, August 2, 2023NON-FINAL ACTION E-MAILED
Wednesday, August 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 23, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 12, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 9, 2024SOU EXTENSION 1 GRANTED
Tuesday, April 9, 2024SOU EXTENSION 1 FILED
Thursday, October 10, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 10, 2024SOU EXTENSION 2 GRANTED
Thursday, October 10, 2024SOU EXTENSION 2 FILED
Tuesday, April 9, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

ignite pfizer development research online providing others services downloadable drug software computer